Price $20.57 |
Market Cap
881.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.09
|
P/S
2.81
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-7.2K
|
FCF
-0.3
|
|
Op. Margin
-9.00%
|
Net Margin
-8.40%
|
ROE
-6.20%
|
ROI
-5.60%
|
|
ROA
-4.80%
|
EPS Growth
17.10%
|
Current Ratio
1.9
|
Debt/Equity
5.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harrow Health Inc (HROW) | $11.52 | - | - | 180.6M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.15 | - | - | 285.1M | Strong Buy |
| LogicMark Inc (LGMK) | $0.76 | - | - | 11.8M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.03 | - | - | 52.7M | Strong Buy |
| CordovaCann Corp (LVRLF) | $0.18 | - | - | 16.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
